The Role of CD8 + T Cells-Producing Interleukin 17 in Pathogenesis of Chronic Hepatitis B — Oak Academic Publishing
Research ArticleOpen AccessGoogle Scholar indexed
The Role of CD8 + T Cells-Producing Interleukin 17 in Pathogenesis of Chronic Hepatitis B
Service d’Immunologie, Faculté de Médecine, de Pharmacie et d’Odontologie (FMPO), Université Cheikh Anta Diop (UCAD), Dakar, Sénégal
,
Unité de Recherche en Immunologie et Immunomodulation (UR2IM), Laboratoire de Microbiologie et de Contrôle de Qualité des Denrées Alimentaires, Ecole Supérieure des Techniques Biologiques et Alimentaires (ESTBA), Université de Lomé, Lomé, Togo
,
Centre National de Transfusion Sanguine (CNTS), Lomé, Togo
,
Service d’Hépato-Gastro-Entérologie, Centre Hospitalier Universitaire Campus, Lomé, Togo
,
Unité de Recherche en Immunologie et Immunomodulation (UR2IM), Laboratoire de Microbiologie et de Contrôle de Qualité des Denrées Alimentaires, Ecole Supérieure des Techniques Biologiques et Alimentaires (ESTBA), Université de Lomé, Lomé, Togo
,
Unité de Recherche en Immunologie et Immunomodulation (UR2IM), Laboratoire de Microbiologie et de Contrôle de Qualité des Denrées Alimentaires, Ecole Supérieure des Techniques Biologiques et Alimentaires (ESTBA), Université de Lomé, Lomé, Togo
,
Unité de Recherche en Immunologie et Immunomodulation (UR2IM), Laboratoire de Microbiologie et de Contrôle de Qualité des Denrées Alimentaires, Ecole Supérieure des Techniques Biologiques et Alimentaires (ESTBA), Université de Lomé, Lomé, Togo
,
Unité de Recherche en Immunologie et Immunomodulation (UR2IM), Laboratoire de Microbiologie et de Contrôle de Qualité des Denrées Alimentaires, Ecole Supérieure des Techniques Biologiques et Alimentaires (ESTBA), Université de Lomé, Lomé, Togo
,
Unité de Recherche en Immunologie et Immunomodulation (UR2IM), Laboratoire de Microbiologie et de Contrôle de Qualité des Denrées Alimentaires, Ecole Supérieure des Techniques Biologiques et Alimentaires (ESTBA), Université de Lomé, Lomé, Togo
,
Service d’Hépato-Gastro-Entérologie, Centre Hospitalier Universitaire Campus, Lomé, Togo
,
University of Bonn, University Hospital Bonn, Institute for Medical Microbiology, Immunology and Parasitology (IMMIP), Bonn, Germany
,
Faculté des Sciences de la Santé (FSS), Université de Lomé, Lomé, Togo
,
Service d’Immunologie, Faculté de Médecine, de Pharmacie et d’Odontologie (FMPO), Université Cheikh Anta Diop (UCAD), Dakar, Sénégal
1 Service d’Immunologie, Faculté de Médecine, de Pharmacie et d’Odontologie (FMPO), Université Cheikh Anta Diop (UCAD), Dakar, Sénégal
2 Unité de Recherche en Immunologie et Immunomodulation (UR2IM), Laboratoire de Microbiologie et de Contrôle de Qualité des Denrées Alimentaires, Ecole Supérieure des Techniques Biologiques et Alimentaires (ESTBA), Université de Lomé, Lomé, Togo
3 Centre National de Transfusion Sanguine (CNTS), Lomé, Togo
4 Service d’Hépato-Gastro-Entérologie, Centre Hospitalier Universitaire Campus, Lomé, Togo
5 Unité de Recherche en Immunologie et Immunomodulation (UR2IM), Laboratoire de Microbiologie et de Contrôle de Qualité des Denrées Alimentaires, Ecole Supérieure des Techniques Biologiques et Alimentaires (ESTBA), Université de Lomé, Lomé, Togo
6 Unité de Recherche en Immunologie et Immunomodulation (UR2IM), Laboratoire de Microbiologie et de Contrôle de Qualité des Denrées Alimentaires, Ecole Supérieure des Techniques Biologiques et Alimentaires (ESTBA), Université de Lomé, Lomé, Togo
7 Unité de Recherche en Immunologie et Immunomodulation (UR2IM), Laboratoire de Microbiologie et de Contrôle de Qualité des Denrées Alimentaires, Ecole Supérieure des Techniques Biologiques et Alimentaires (ESTBA), Université de Lomé, Lomé, Togo
8 Unité de Recherche en Immunologie et Immunomodulation (UR2IM), Laboratoire de Microbiologie et de Contrôle de Qualité des Denrées Alimentaires, Ecole Supérieure des Techniques Biologiques et Alimentaires (ESTBA), Université de Lomé, Lomé, Togo
9 Unité de Recherche en Immunologie et Immunomodulation (UR2IM), Laboratoire de Microbiologie et de Contrôle de Qualité des Denrées Alimentaires, Ecole Supérieure des Techniques Biologiques et Alimentaires (ESTBA), Université de Lomé, Lomé, Togo
10 Service d’Hépato-Gastro-Entérologie, Centre Hospitalier Universitaire Campus, Lomé, Togo
11 University of Bonn, University Hospital Bonn, Institute for Medical Microbiology, Immunology and Parasitology (IMMIP), Bonn, Germany
12 Faculté des Sciences de la Santé (FSS), Université de Lomé, Lomé, Togo
13 Service d’Immunologie, Faculté de Médecine, de Pharmacie et d’Odontologie (FMPO), Université Cheikh Anta Diop (UCAD), Dakar, Sénégal
Chronic hepatitis B (CHB) remains a major global public health burden, with approximately 1.1 million deaths annually. The current classification of chronic hepatitis B virus (HBV) infection into four distinct phases is based exclusively on virological, biochemical, and histological parameters without taking into account immunological markers, even though the clinical course and outcome of the infection are mainly linked to the immune response. This study was designed to assess CD8 + IFN γ + (Tc1), CD8 + IL17A + (Tc17) and the expression of perforin and Granzyme B in peripheral blood CD8 + T cells to elucidate their functional implications at different phases of chronic hepatitis B infection. Whole blood from 20 chronic Hepatitis B patients and 20 healthy controls recruited respectively at the hepato-gastro-enterology department, CHU Campus and National Blood Transfusion Center (CNTS) of Lomé were stimulated using phorbol 12-myristate 13-acetate (PMA) and ionomycin. CD8 + , CD8 + IFN γ + , CD8 + IL17A + , CD8 + Perforin + and CD8 + GranzymeB + T cells frequency were characterized by intracellular cytokine staining (ICS) combined with flow cytometry method. All patients were positive for anti-HBe and negative for HBeAg. Among them, 7 showed viral replication (active carrier) and 4 showed diseases. We observed that CHB patients displayed a decrease in circulating CD8 + T cells and an increase in CD8 + IL17A + T cells. This increase in CD8 + IL17A + T cells was associated with CHB. Our study revealed that CD8 + T cells profile was not impaired at different stages of CHB.
KeywordsHepatitis B VirusChronic Hepatitis BHBeAg NegativeCytotoxic T LymphocytesCD8 T Cells
Razavi-Shearer, D., Gamkrelidze, I., Pan, C., Jia, J., Berg, T., Gray, R., et al. (2023) Global Prevalence, Cascade of Care, and Prophylaxis Coverage of Hepatitis B in 2022: A Modelling Study. The Lancet Gastroenterology & Hepatology , 8, 879-907. https://doi.org/10.1016/s2468-1253(23)00197-8
World Health Organization (2024) Hepatitis B. https://www.who.int/news-room/fact-sheets/detail/hepatitis-b
Sheena, B.S., Hiebert, L., Han, H., Ippolito, H., Abbasi-Kangevari, M., Abbasi-Kangevari, Z., et al. (2022) Global, Regional, and National Burden of Hepatitis B, 1990-2019: A Systematic Analysis for the Global Burden of Disease Study 2019. The Lancet Gastroenterology & Hepatology , 7, 796-829. https://doi.org/10.1016/s2468-1253(22)00124-8
Russell, J.H. and Ley, T.J. (2002) Lymphocyte-Mediated Cytotoxicity. Annual Review of Immunology , 20, 323-370. https://doi.org/10.1146/annurev.immunol.20.100201.131730
Susanto, O., Trapani, J.A. and Brasacchio, D. (2012) Controversies in Granzyme Biology. Tissue Antigens , 80, 477-487. https://doi.org/10.1111/tan.12014
Lieberman, J. and Fan, Z. (2003) Nuclear War: The Granzyme A-bomb. Current Opinion in Immunology , 15, 553-559. https://doi.org/10.1016/s0952-7915(03)00108-0
Ma, W., Yao, X., Peng, Q. and Chen, D. (2019) The Protective and Pathogenic Roles of IL-17 in Viral Infections: Friend or Foe? Open Biology , 9, Article No. 190109. https://doi.org/10.1098/rsob.190109
Koh, C., Lee, S., Kwak, M., Kim, B. and Chung, Y. (2023) CD8 T-Cell Subsets: Heterogeneity, Functions, and Therapeutic Potential. Experimental & Molecular Medicine , 55, 2287-2299. https://doi.org/10.1038/s12276-023-01105-x
Wiegand, S.B., Beggel, B., Wranke, A., Aliabadi, E., Jaroszewicz, J., Xu, C., et al. (2019) Soluble Immune Markers in the Different Phases of Chronic Hepatitis B Virus Infection. Scientific Reports , 9, Article No. 14118. https://doi.org/10.1038/s41598-019-50729-5
Wang, S., Leus, M., Cornberg, M., Ghany, M., Hwang, C., Lim, S.G., et al. (2025) Standardising HBV Nomenclature: A Call to Action from the HBV Forum. The Lancet Gastroenterology & Hepatology , 10, 710-712. https://doi.org/10.1016/s2468-1253(25)00158-x
Lampertico, P., Agarwal, K., Berg, T., Buti, M., Janssen, H.L.A., Papatheodoridis, G., et al. (2017) EASL 2017 Clinical Practice Guidelines on the Management of Hepatitis B Virus Infection. Journal of Hepatology , 67, 370-398. https://doi.org/10.1016/j.jhep.2017.03.021
Cornberg, M., Sandmann, L., Jaroszewicz, J., Kennedy, P., Lampertico, P., Lemoine, M., et al. (2025) EASL Clinical Practice Guidelines on the Management of Hepatitis B Virus Infection. Journal of Hepatology , 83, 502-583. https://doi.org/10.1016/j.jhep.2025.03.018
European Association for the Study of the Liver (2012) EASL Clinical Practice Guidelines: Management of Chronic Hepatitis B Virus Infection. Journal of Hepatology , 57, 167-185. https://doi.org/10.1016/j.jhep.2012.02.010
World Health Organization (2024) Guidelines for the Prevention, Diagnosis, Care and Treatment for People with Chronic Hepatitis B Infection. World Health Organization. https://iris.who.int/bitstream/handle/10665/376353/9789240090903-eng.pdf
Balmasova, I.P., Yushchuk, N.D., Mynbaev, O.A., Alla, N.R., Malova, E.S., Shi, Z. et al. (2014) Immunopathogenesis of Chronic Hepatitis B. World Journal of Gastroenterology , 20, 14156-14171. https://doi.org/10.3748/wjg.v20.i39.14156
Nguyen, M.H., Wong, G., Gane, E., Kao, J. and Dusheiko, G. (2020) Hepatitis B Virus: Advances in Prevention, Diagnosis, and Therapy. Clinical Microbiology Reviews , 33, e00046-19. https://doi.org/10.1128/cmr.00046-19
Rukunuzzaman, M., Benzamin, M. and Sultana, K. (2018) Management of Chronic HBV Infection in Children. In: Ozaras, R. and Tahan, V., Eds., Viral Hepatitis : Chronic Hepatitis B , Springer, 11-23. https://doi.org/10.1007/978-3-319-93449-5_2
Voulgaris, T., Vlachogiannakos, J., Ioannidou, P., Papageorgiou, M., Zampeli, E., Karagiannakis, D., et al. (2017) Adherence to Follow-Up and Treatment Recommendations in Greek and Immigrant Patients with Chronic Hepatitis B in Greece. European Journal of Gastroenterology & Hepatology , 29, 264-270. https://doi.org/10.1097/meg.0000000000000788
Ribeiro, C.R.d.A., de Almeida, N.A.A., Martinelli, K.G., Pires, M.A., Mello, C.E.B., Barros, J.J., et al. (2021) Cytokine Profile during Occult Hepatitis B Virus Infection in Chronic Hepatitis C Patients. Virology Journal , 18, 264-270. https://doi.org/10.1186/s12985-021-01487-2
Gnodja, T., Kadanga, M.M., Bara, F.D., Simfele, H.C., Kolou, M. and Mbengue, B. (2025) Optimizing Whole Blood Stimulation Conditions for Intracellular Cytokine Staining: A Solution for Resource-Limited Laboratories and Field Studies. Zenodo. https://doi.org/10.5281/ZENODO.15318008
Minuk, G.Y., Orr, P.S., Brown, R., Macdonald, S., Chaudhary, R.K. and Temple, P. (2000) Pre-Core Mutant Infections in the Canadian Inuit. Journal of Hepatology , 33, 781-784. https://doi.org/10.1016/s0168-8278(00)80310-4
Ankouane, F., Kowo, M., Njoya, O., Sida, M.B., Tzeuton, C. and Ndam, E.C.N. (2015) Epidemiological Aspects of HBeAg Negative Chronic Hepatitis B in Yaounde, Cameroon. Health Sciences and Disease , 16, No. 3.
Sayed, S.K. and kobeisy, M.A. (2012) The Relationship between Core Promoter Mutation of Hepatitis B Virus, Viral Load and Hepatitis B E Antigen Status in Chronic Hepatitis B Patients. Cellular Immunology , 276, 35-41. https://doi.org/10.1016/j.cellimm.2012.03.003
Tsugeno, H., Yamada, G., Kinoshita, M., Shimomura, H., Iwasaki, Y. and Tsuji, T. (2002) Quantitative Analysis of Wild-Type and Precore Mutant Hepatitis B Virus in Carriers. Hepatology Research , 23, 48-54. https://doi.org/10.1016/s1386-6346(01)00156-5
Lim, C.K., Tan, J.T.M., Khoo, J.B.S., Ravichandran, A., Low, H.M., Chan, Y.C., et al. (2006) Correlations of HBV Genotypes, Mutations Affecting HBeAg Expression and HBeAg/Anti-HBE Status in HBV Carriers. International Journal of Medical Sciences , 3, 14-20. https://doi.org/10.7150/ijms.3.14
Wang, C., Ji, D., Chen, J., Shao, Q., Li, B., Liu, J., et al. (2017) Hepatitis Due to Reactivation of Hepatitis B Virus in Endemic Areas among Patients with Hepatitis C Treated with Direct-Acting Antiviral Agents. Clinical Gastroenterology and Hepatology , 15, 132-136. https://doi.org/10.1016/j.cgh.2016.06.023
Lin, C.L. and Kao, J.H. (2015) Hepatitis B Virus Genotypes and Variants. Cold Spring Harbor Perspectives in Medicine , 5, a021436. https://doi.org/10.1101/cshperspect.a021436
Liaw, Y., Brunetto, M.R. and Hadziyannis, S. (2010) The Natural History of Chronic HBV Infection and Geographical Differences. Antiviral Therapy , 15, 25-33. https://doi.org/10.3851/imp1621
Korobova, Z.R., Arsentieva, N.A., Butenko, A.A., Batsunov, O.K., Lyubimova, N.E., Ostankova, Y.V., et al. (2025) Disease-Associated Shifts in Minor T Cell Subpopulations Define Distinct Immunopathology in HBV Vs. HCV Infection. International Journal of Molecular Sciences , 26, Article 7761. https://doi.org/10.3390/ijms26167761
Xie, S., Yang, L., Bi, X., Deng, W., Jiang, T., Lin, Y., et al. (2022) Cytokine Profiles and CD8+ T Cells in the Occurrence of Acute and Chronic Hepatitis B. Frontiers in Immunology , 13, Article 1036612. https://doi.org/10.3389/fimmu.2022.1036612
Svicher, V., Salpini, R., D’Anna, S., Piermatteo, L., Iannetta, M., Malagnino, V., et al. (2023) New Insights into Hepatitis B Virus Lymphotropism: Implications for HBV-Related Lymphomagenesis. Frontiers in Oncology , 13, Article 1143258. https://doi.org/10.3389/fonc.2023.1143258
Zhang, G., Zhang, T., Zhao, Q., Xie, C., Lin, C. and Gao, Z. (2018) Increased Il-17-Producing CD8 + T Cell Frequency Predicts Short-Term Mortality in Patients with Hepatitis B Virus-Related Acute-On-Chronic Liver Failure. Therapeutics and Clinical Risk Management , 14, 2127-2136. https://doi.org/10.2147/tcrm.s184809
Lückel, C., Picard, F.S.R. and Huber, M. (2020) TC17 Biology and Function: Novel Concepts. European Journal of Immunology , 50, 1257-1267. https://doi.org/10.1002/eji.202048627
Dalegaard, M.I., Winckelmann, A., Fahnøe, U., Underwood, A.P., Pedersen, A.G., Bollerup, S., et al. (2025) Higher Rates of Viral Evolution in Chronic Hepatitis B Patients Linked to Predicted T Cell Epitopes. Viruses , 17, Article 684. https://doi.org/10.3390/v17050684
Gaba, F.M., Mbengue, B., Diop, M., Diouf, D., Ka, S., Niang, D.G.M., et al. (2019) Predictive Significance of IL-17A Serum Levels during Chemotherapy in Senegalese Women with Cervical Cancer. Open Journal of Immunology , 9, 37-47. https://doi.org/10.4236/oji.2019.94004
Kolou, M., Katawa, G., Tchopba, C.N., Gnodja, T., Amessoudji, M.O., Tchadie, P.E. et al. (2023) Reduced IL-17A Producing Lymphocytes in Chronic Hepatitis C Individuals Treated with Sofosbuvir/Velpatasvir at CHU Campus of Lomé, Togo. African Journal of Immunology Research , 11, 1-9.